About Summit:
Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC)
HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
Colorectal Cancer (CRC)
HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland.
Overview of Role:
The Chief Commercial Officer (CCO) will be a key member of the executive leadership team, responsible for
developing and executing the company's commercial strategy. This role will oversee all aspects of
commercialization, including market access, sales, marketing, and distribution. The CCO will work closely with
cross-functional teams to ensure successful product launches and sustainable growth in global markets.
Role and Responsibilities:
- Develop and execute a comprehensive commercial strategy for ivonescimab and drive the successful
launch and growth of the company's products in global markets - Lead market access strategies, including pricing, reimbursement, and health economics, to ensure
optimal market penetration and patient access - Build and lead high-performing sales and marketing teams, establishing clear goals, performance
metrics, and incentive programs that align with the Company’s values and strategic deliverables - Oversee the planning and execution of product launches, ensuring alignment with regulatory
requirements and market needs - Identify and pursue strategic partnerships, alliances, and licensing opportunities to expand the
company's commercial footprint - Foster strong relationships with key stakeholders, including healthcare providers, payers, and patient
advocacy groups - Develop and manage the commercial budget, ensuring efficient allocation of resources to achieve
commercial objectives - Monitor market trends, competitive landscape, and customer insights to inform strategic decisionmaking and identify growth opportunities
- Ensure all commercial activities comply with relevant regulations and industry standards
- All other duties as assigned
Experience, Education and Specialized Knowledge and Skills:
- Bachelor’s degree in business, Marketing, Life Sciences, or a related field; MBA or advanced degree
preferred - Minimum of 15+ years of experience in commercial leadership roles within the pharmaceutical or
biotechnology industry, with direct experience in NSCLC/NDCLC and solid tumors - Experience with blockbuster drug commercial launches in NSCLC/NDCLC and/or solid tumors within
the past 5 years - Proven track record of successfully launching and commercializing pharmaceutical products in global
markets - Strong strategic thinking and analytical skills, with the ability to translate market insights into
actionable strategies - Excellent leadership and team-building skills, with a demonstrated ability to inspire and motivate crossfunctional teams
- Exceptional communication and interpersonal skills, with the ability to build and maintain relationships
with key stakeholders - In-depth knowledge of market access, pricing, reimbursement, and health economics.
- Experience in business development and strategic partnerships
- Ability to thrive in a fast-paced, dynamic environment and adapt to changing market conditions
- Travel up to 50%
This is the pay for this position
Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation.
Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at [email protected] to obtain prior written authorization before referring any candidates to Summit.
Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status.
Skills Required
- Bachelor’s degree in business, marketing, life sciences, or a related field
- MBA or advanced degree
- 15+ years of commercial leadership experience in the pharmaceutical or biotechnology industry
- Direct experience in NSCLC/NDCLC and solid tumors
- Experience with blockbuster drug commercial launches in NSCLC/NDCLC and/or solid tumors within the past five years
- Proven track record launching and commercializing pharmaceutical products in global markets
- Strong strategic thinking and analytical skills
- Excellent leadership and team-building skills
- Exceptional communication and interpersonal skills
- In-depth knowledge of market access, pricing, reimbursement, and health economics
- Experience in business development and strategic partnerships
- Ability to thrive in a fast-paced, dynamic environment and adapt to changing market conditions
- Ability to travel up to 50%
What We Do
Summit Mission Statement: To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to: improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs. To identify and control promising product candidates based on exceptional scientific development and administrational expertise, develop our products in a rapid, cost-efficient manner, and to engage commercialization and/or development partners when appropriate. We accomplish this by building a team of world class professional scientists and business administrators that apply their experience and knowledge to this mission. Team Summit exists to pose, strategize, and execute a path forward in medicinal therapeutic health care that places Summit in a well-deserved, top market share, leadership position. Team Summit assumes full responsibility for stimulating continuous expansion of knowledge, ability, capability, and well-being for all involved stakeholders and highly-valued shareholders. Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Miami, Florida, and we have additional offices in Palo Alto, California, Princeton, New Jersey, Oxford, UK, and Dublin, Ireland.
